The green-energy giant’s $3.5 bln Shanghai listing ought to benefit from President Xi Jinping's climate push. But regulators are cutting wind and solar subsidies, and late government payments are ... ( read original story ...)
SGX Nifty up 90 points; here’s what changed for market while you were sleeping
Asian shares edged cautiously higher catching the tailwind from a bounce on Wall Street and ahead of expected upbeat readings on the Chinese economy. MSCI's broadest index of Asia-Pacific shares ... ( read original story ...)
AffaMed Therapeutics Announces Appointment of Vijay Karwal as Chief Financial Officer
AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to addressing critical unmet medical needs in ophthalmic, ... ( read original story ...)
Shanghai Bride: Her Tumultuous Life’s Journey to the West
This is an autobiography of a woman of unusual strength anddetermination who grew up in 1930s' Shanghai. Born to a traditionalfamily of China's ... ( read original story ...)
China approves three new IPO requests
China's securities controller has accepted the initial public offering (IPO) applications of three companies. The China Securities Regulatory Commission stated in a report that Wuxi ... ( read original story ...)
Shanghai-based Atour to raise USD 2 bln in NYSE IPO
Shanghai-based hotel company Atour is planning for a listing on the New York Stock Exchange (NYSE), with the stipulated IPO value to be as much as USD 2 bln. ( read original story ...)
Larkspur Health Acquisition files to go public as this year’s SPAC flood surges over $14B
Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here. Another day, another SPAC vying for a spot on Nasdaq. On Wednesday, OncoSec Medical CEO Daniel ... ( read original story ...)